


| Key | % Net Assets |
|---|---|
| 5.9% | |
| 5.3% | |
| 5.3% | |
| 5.2% | |
| 78.3% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 5.9% |
| AstraZeneca | 5.3% |
| Vodafone Group | 5.3% |
| BAE Systems | 5.2% |
| Royal Dutch Shell | 5.0% |
| Babcock International | 4.8% |
| Croda International | 4.5% |
| British American Tobacco | 4.2% |
| VT Group | 4.2% |
| BP | 4.1% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 01/11/2001 |
|---|---|
| Fund Manager | Tim Steer |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | n/a |
| Savings | 100 |
| Charges | |
|---|---|
| Initial | 5.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.12 |
You are here: research